Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock
(MedPage Today) -- ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed.
In more than 350 patients receiving... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 9, 2024 Category: Radiology Source Type: news
Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock
The results, specific to STEMI patients with cardiogenic shock, are striking, experts say, but much work lies ahead. ATLANTA, GA—For patients with acute MI complicated by cardiogenic shock (AMICS), the routine use of mechanical circulatory support (MCS) with the Impella CP (Abiomed) microaxial…#atlanta #amics #impellacpabiomed #dangershock #jacobeifermøller #phd #denmark #acc #nejm #sunilvrao (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Impella CP Improves Survival in STEMI, Cardiogenic Shock Impella CP Improves Survival in STEMI, Cardiogenic Shock
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2024 Category: Cardiology Tags: Cardiology Source Type: news
Impella Saves Live in CS, but Patient Selection Key Impella Saves Live in CS, but Patient Selection Key
In the first randomized trial of Impella in a select group of patients with AMI and cardiogenic shock, the device saved lives. The high rate of serious adverse events calls us to pay attention to the nuances of the data, says John Mandrola, MD.theheart.org on Medscape (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 7, 2024 Category: Intensive Care Tags: Cardiology Commentary Source Type: news
Impella Saves Lives in CS, but Patient Selection Key Impella Saves Lives in CS, but Patient Selection Key
In the first randomized trial of Impella in a select group of patients with AMI and cardiogenic shock, the device saved lives. The high rate of serious adverse events calls us to pay attention to the nuances of the data, says John Mandrola, MD.theheart.org on Medscape (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 7, 2024 Category: Emergency Medicine Tags: Cardiology Commentary Source Type: news
Shock and modified shock indices in predicting poisoning severity and outcomes in acute aluminum phosphide poisoned patients - Ghonem MM, Abdelnoor AA, Hodeib AA.
BACKGROUND: Severe refractory hypotension and cardiogenic shock are the main contributors to death in acute aluminum phosphide (ALP) poisoning. Shock index (SI) and modified shock index (MSI) are easily obtained parameters that reflect shock at an early st... (Source: SafetyLit)
Source: SafetyLit - January 8, 2024 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
Lab Notes: Parkinson's disease drug developer Enterin raises $5M
This week's Lab Notes has items on a Philadelphia biotechnology firm's multimillion-dollar stock sale, a Philadelphia gene-editing company's approval for a study in Australia, a progress update on a Buck County firm's experimental treatment for cardiogenic shock and more. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 22, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
Medscape Now! Hot Topics in Women ’s Health December 2023 Medscape Now! Hot Topics in Women ’s Health December 2023
Find out about how gender impacts outcomes in PTSD and cardiogenic shock.Medscape Education Clinical Briefs (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 11, 2023 Category: Transplant Surgery Tags: Ob/Gyn & Women ' s Health Clinical Brief Source Type: news
Women Have Worse Outcomes in Cardiogenic Shock Women Have Worse Outcomes in Cardiogenic Shock
A new analysis of a large contemporary registry of patients with cardiogenic shock has shown worse outcomes for women than men, driven particularly by those with shock related to heart failure.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 9, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Trial: ECMO Doesn't Save Lives in Cardiogenic Shock
(MedPage Today) -- AMSTERDAM -- Venoarterial extracorporeal membrane oxygenation (VA ECMO) didn't improve survival with cardiogenic shock, the ECLS-SHOCK trial showed.
This form of extracorporeal life support (ECLS) yielded similar 30-day all... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 27, 2023 Category: Cardiology Source Type: news
Short-term Systemic Glucocorticoids and Cardiogenic Shock Short-term Systemic Glucocorticoids and Cardiogenic Shock
How prevalent is the systemic use of glucocorticoids in patients with cardiogenic shock, and what are the effects of their use on outcomes and survival?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 6, 2023 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
ECMO Signal of Benefit for Cardiogenic Shock After MI ECMO Signal of Benefit for Cardiogenic Shock After MI
Though based on small numbers in a halted trial, ECMO was associated with reduced mortality for PCI patients in MI-related cardiogenic shock, results of the EURO SHOCK trial suggest.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 30, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
Evidence of TAVR Benefit Extends to Cardiogenic Shock Evidence of TAVR Benefit Extends to Cardiogenic Shock
Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new registry data suggest.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 18, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Tension pneumopericardium causing cardiogenic shock due to blunt injury to the chest - Pearl L, Kerby E, Pansuriya S, Alnajjar R, Lim J.
Pneumopericardium is an exceptionally uncommon phenomenon in the setting of blunt polytrauma. It is imperative for trauma providers to identify tension pneumopericardium despite its rarity. A 22-year-old male motorcyclist presented to the hospital after co... (Source: SafetyLit)
Source: SafetyLit - May 11, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Mayo Clinic Minute: What is cardiogenic shock?
Cardiogenic shock is a condition where the heart is too weak to pump blood and oxygen to the brain and organs. Fatal if not treated immediately, the condition affects approximately 50,000 people in the U.S. Dr. Parag Patel, a Mayo Clinic cardiologist, explains what cardiogenic shock is and how it's treated. Watch: The Mayo Clinic Minute https://www.youtube.com/watch?v=u0sTu9uIbSQ Journalists: Broadcast-quality video (0:56) is in the downloads at the end of this post. Please courtesy: "Mayo Clinic… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 14, 2023 Category: Databases & Libraries Source Type: news
